SAIF Partners IV L.P.

13D and 13G Filings

13D/G filings: 13D on 1 security, 13G on 1 security
Location: Hong Kong
CIK: 0001472789
Form D filings: 1 filing
All SEC filings: View on sec.gov

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Sinovac Biotech Ltd. 13D/A Amendment 20 SVA · P8696W104	SVA	P8696W104	15.0%	10,780,820	13D/A Amendment 20	12/17/2025 Event 12/15/2025
SAIF Partners IV L.P.			15.0%	10,780,820
Saif IV GP, L.P.			15.0%	10,780,820
SAIF IV GP Capital Ltd.			15.0%	10,780,820
Amprius Technologies, Inc. 13G/A Amendment 2 AMPX · 03214Q108	AMPX	03214Q108	0%	0	13G/A Amendment 2	8/14/2025 Event 6/30/2025
SAIF Partners IV L.P.			0%	0
Saif IV GP, L.P.			0%	0
SAIF IV GP Capital Ltd.			0%	0
Andrew Y. Yan			0%	0
Sinovac Biotech Ltd. 13D/A Amendment 19 SVA · P8696W104	SVA	P8696W104	15.0%	10,780,820	13D/A Amendment 19	7/14/2025 Event 7/10/2025
SAIF Partners IV L.P.			15.0%	10,780,820
Saif IV GP, L.P.			15.0%	10,780,820
SAIF IV GP Capital Ltd.			15.0%	10,780,820
Sinovac Biotech Ltd. 13D/A Amendment 18 SVA · P8696W104	SVA	P8696W104	15.0%	10,780,820	13D/A Amendment 18	6/17/2025 Event 6/16/2025
SAIF Partners IV L.P.			15.0%	10,780,820
Saif IV GP, L.P.			15.0%	10,780,820
SAIF IV GP Capital Ltd.			15.0%	10,780,820
Sinovac Biotech Ltd. 13D/A Amendment 17 SVA · P8696W104	SVA	P8696W104	15.0%	10,780,820	13D/A Amendment 17	5/23/2025 Event 5/23/2025
SAIF Partners IV L.P.			15.0%	10,780,820
Saif IV GP, L.P.			15.0%	10,780,820
SAIF IV GP Capital Ltd.			15.0%	10,780,820
Amprius Technologies, Inc. 13G/A Amendment 1 AMPX · 03214Q108	AMPX	03214Q108	6.3%	7,608,537	13G/A Amendment 1	5/15/2025 Event 3/31/2025
SAIF Partners IV L.P.			6.3%	7,608,537
Saif IV GP, L.P.			6.3%	7,608,537
SAIF IV GP Capital Ltd.			6.3%	7,608,537
Andrew Y. Yan			6.3%	7,608,537
Sinovac Biotech Ltd. 13D/A Amendment 16 SVA · P8696W104	SVA	P8696W104	15.0%	10,780,820	13D/A Amendment 16	4/29/2025 Event 4/28/2025
SAIF Partners IV L.P.			15.0%	10,780,820
Saif IV GP, L.P.			15.0%	10,780,820
SAIF IV GP Capital Ltd.			15.0%	10,780,820
Sinovac Biotech Ltd. 13D/A Amendment 15 SVA · P8696W104	SVA	P8696W104	15.0%	10,780,820	13D/A Amendment 15	3/19/2025 Event 3/18/2025
SAIF Partners IV L.P.			15.0%	10,780,820
Saif IV GP, L.P.			15.0%	10,780,820
SAIF IV GP Capital Ltd.			15.0%	10,780,820
Sinovac Biotech Ltd 13D/A Amendment 14 SVA · P8696W104	SVA	P8696W104	15.0%	10,780,820	13D/A Amendment 14	2/19/2025 Event 2/18/2025
SAIF Partners IV L.P.			15.0%	10,780,820
Saif IV GP L.P.			15.0%	10,780,820
SAIF IV GP Capital Ltd.			15.0%	10,780,820

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.